Literature DB >> 24305919

Impact of surgery on quality of life in patients with hepatocellular carcinoma.

Yoshihiro Mise1, Shouichi Satou, Takeaki Ishizawa, Junichi Kaneko, Taku Aoki, Kiyoshi Hasegawa, Yasuhiko Sugawara, Masatoshi Makuuchi, Norihiro Kokudo.   

Abstract

BACKGROUND: Liver resection is the mainstay of curative treatment for localized hepatocellular carcinoma (HCC). However, the impact of surgery for HCC on quality of life (QOL) has not been well assessed.
METHODS: Health-related QOL was assessed using the Short Form-36 questionnaire in 108 patients who underwent a liver resection for HCC between January 2004 and January 2008. The QOL assessment was scheduled before and every 3 months after the operation. Patients were divided into two groups based on patient-, tumor-, and surgery-related variables. The physical component summary (PCS) and mental component summary (MCS) were compared between the two groups.
RESULTS: Altogether, 69 patients (64 %) completed the consecutive QOL assessments until 6 months after surgery. At 3 months, the PCS scores were significantly lower for women and for patients who had undergone thoracotomy than among men (p = 0.010) and patients who had not undergone thoracotomy (p = 0.048), respectively. No significant differences in any of the PCS scores were observed at 6 months. No significant differences in the MCS scores were observed between the groups throughout the investigation, and improvement relative to the preoperative status was observed at 6 months.
CONCLUSIONS: Physical impairments in the QOL after surgery had returned to the baseline at 6 months, and the postoperative mental QOL improved relative to the preoperative state. The surgical candidates were expected to have a satisfactory QOL regardless of the preoperative status and surgical outcomes. A thoracoabdominal approach had a transient negative impact on the physical health status.

Entities:  

Mesh:

Year:  2014        PMID: 24305919     DOI: 10.1007/s00268-013-2342-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  55 in total

1.  Repeat hepatectomy for recurrent hepatocellular carcinoma.

Authors:  Toshiyuki Itamoto; Hideki Nakahara; Hironobu Amano; Toshihiko Kohashi; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  Surgery       Date:  2007-05       Impact factor: 3.982

2.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Quality of life after curative liver resection: a single center analysis.

Authors:  Helge Bruns; Kirsten Krätschmer; Ulf Hinz; Anette Brechtel; Monika Keller; Markus-W Büchler; Peter Schemmer
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

4.  Candidates for liver transplantation for cancer: physical, psychological, and social conditions.

Authors:  Laura Gangeri; Marcello Tamburini; Claudia Borreani; Cinzia Brunelli; Guido Miccinesi; Luciana Murru; Paolo Boeri; Vincenzo Mazzaferro
Journal:  Transplantation       Date:  2002-05-27       Impact factor: 4.939

5.  Gender differences in health-related quality of life in patients with HIV/AIDS.

Authors:  Joseph M Mrus; Paige L Williams; Joel Tsevat; Susan E Cohn; Albert W Wu
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

6.  Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.

Authors:  Shiow-Ching Shun; Chien-Hung Chen; Jin-Chuan Sheu; Ja-Der Liang; Jyh-Chin Yang; Yeur-Hur Lai
Journal:  Oncologist       Date:  2012-04-17

7.  Assessment of symptom experience in patients undergoing hepatic resection or ablation.

Authors:  Sebastian Eid; Arnold J Stromberg; Susan Ames; Susan Ellis; Kelly M McMasters; Robert C G Martin
Journal:  Cancer       Date:  2006-12-01       Impact factor: 6.860

8.  Correlation of health-related quality of life after liver transplant with the Model for End-Stage Liver Disease score.

Authors:  Eric T Castaldo; Irene D Feurer; Robert T Russell; C Wright Pinson
Journal:  Arch Surg       Date:  2009-02

9.  A new approach for liver surgery. Transdiaphragmatic hepatectomy for cirrhotic patients with hepatocellular carcinoma.

Authors:  M Shimada; T Matsumata; A Taketomi; K Shirabe; K Yamamoto; H Itasaka; K Sugimachi
Journal:  Arch Surg       Date:  1995-02

10.  Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy.

Authors:  Shiow-Ching Shun; Jeng-Fong Chiou; Yeur-Hur Lai; Po-Jui Yu; Lin-Lin Wei; Jo-Ting Tsai; Chung-Yu Kao; Ya-Li Hsiao
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

View more
  10 in total

1.  Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases.

Authors:  Yoshihiro Mise; Reza J Mehran; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2014-06-20       Impact factor: 3.982

2.  The quality of life after surgery for HCC can support the choice of this treatment.

Authors:  I Di Carlo; A Toro
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

3.  The extent of hepatectomy does not affect physical QOL in patients with HCC: reply.

Authors:  Yoshihiro Mise; Norihiro Kokudo
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

4.  Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

Authors:  Chetana Lim; Philippe Compagnon; Mylène Sebagh; Chady Salloum; Julien Calderaro; Alain Luciani; Gérard Pascal; Alexis Laurent; Eric Levesque; Umberto Maggi; Cyrille Feray; Daniel Cherqui; Denis Castaing; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2015-05-16       Impact factor: 3.647

Review 5.  Value of quality of life analysis in liver cancer: A clinician's perspective.

Authors:  Leung Li; Winnie Yeo
Journal:  World J Hepatol       Date:  2017-07-18

Review 6.  Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life.

Authors:  Daneng Li; Sabrina Sedano; Rebecca Allen; Jun Gong; May Cho; Sunil Sharma
Journal:  Cancers (Basel)       Date:  2019-06-18       Impact factor: 6.639

7.  Short- and Long-Term Outcomes of a Transdiaphragmatic Approach for Simultaneous Resection of Colorectal Liver and Lung Metastases.

Authors:  Mario De Bellis; Yoshikuni Kawaguchi; Gregor Duwe; Hop S Tran Cao; Reza J Mehran; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2020-10-29       Impact factor: 3.452

8.  Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis.

Authors:  Feng Xie; Fang Zhu; Zaiming Lu; Zhengrong Liu; Hongyan Wang
Journal:  Oncol Lett       Date:  2016-05-24       Impact factor: 2.967

Review 9.  Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018.

Authors:  Danbee Kang; Sungkeun Shim; Juhee Cho; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2020-06       Impact factor: 3.500

10.  Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies.

Authors:  Kerstin Wohlleber; Patrick Heger; Pascal Probst; Christoph Engel; Markus K Diener; André L Mihaljevic
Journal:  Qual Life Res       Date:  2021-07-20       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.